Table 1.
Variables | HR (95%CI) | P | Adjusted HR (95%CI) | P |
---|---|---|---|---|
Overall survival | ||||
SMAD4 LOH and mutations | ||||
Wild type | Reference | Reference | ||
LOH and/or mutations | 1.95 (1.05–3.62) | 0.034* | 2.08 (1.10–3.92) | 0.024* |
SMAD4 expression | ||||
High | Reference | Reference | ||
Low | 4.30 (1.02–18.15) | 0.047* | 4.09 (0.93–18.00) | 0.063 |
Disease-free survival | ||||
SMAD4 LOH and mutations | ||||
Wild type | Reference | Reference | ||
LOH and/or mutations | 2.08 (1.21–3.57) | 0.008* | 1.97 (1.14–3.42) | 0.016* |
SMAD4 expression | ||||
High | Reference | Reference | ||
Low | 4.43 (1.05–18.69) | 0.043* | 4.54 (1.03–20.12) | 0.046* |
Adjusted for age, gender, and clinical stage.
HR, hazard ratio; CI, confidence interval.